BioSpace News Archive

Aldeyra Therapeutics Announces First Patient Enrolled in Allergic Conjunctivitis Phase 3 Clinical Trial

Aldeyra is a biotechnology company devoted to development of next-generation medicines to improve the lives of patients with inflammatory diseases

April 24, 2018

·

6 min read

Pharm Country

AHM Industry Conference to Explore Innovations in Engagement of Healthcare Professionals

On May 1, 2018, AHM will host a conference for the Life Sciences industry, sharing resources and ideas to stay one step ahead of the game changers facing the Life Sciences industry--with compliance, HCP Engagements and meetings.

April 24, 2018

·

2 min read

Business

Independent Living Systems Earns Accreditation From the National Committee for Quality Assurance

Independent Living Systems (ILS) has received the National Committee for Quality Assurance’s (NCQA) Accreditation for Case Management - Long Term Services and Supports (CM-LTSS).

April 24, 2018

·

1 min read

Drug Development

Tarveda Therapeutics Announces Dosing of First Patient in Phase 1/2a Study of PEN-866 for Patients with Solid Malignancies

Phase 2a trial of PEN-221 has initiated

April 24, 2018

·

5 min read

Policy

Argentum and Cosmo Settle Patent Dispute Over UCERIS®

Argentum Pharmaceuticals LLC, a generic pharmaceutical company, announced that it has reached a settlement agreement with Cosmo Technologies Limited related to Argentum’s inter partes review petition challenging an Orange Book-listed patent for UCERIS® (budesonide).

April 24, 2018

·

1 min read

Business

Perrigo To Release First Quarter Calendar Year 2018 Financial Results On May 8, 2018

Separately, the Company announced that it will present at the Deutsche Bank Healthcare Conference on May 9, 2018

April 24, 2018

·

4 min read

Business

Jeffrey Modell Foundation and X4 Pharmaceuticals to Sponsor First Genetic Screening Study for Patients with WHIM Syndrome

Study aims to establish a genetic screening approach to aid in diagnosis of patients with WHIM syndrome

April 24, 2018

·

6 min read

Biotech Beach

Oral Biologics Delivery Could Be The Key For Biosimilars To Gain Market Share From Blockbuster Drugs

Doctors believe moving Rheumatoid Arthritis and Crohn’s Disease patients from AbbVie’s injectable Humira® (adalimumab) to an oral adalimumab would improve patient compliance

April 24, 2018

·

4 min read

ARANZ Medical’s pedigree in clinical trials makes Silhouette(R) the obvious choice for new research

ARANZ Medical’s Silhouette skin imaging and measuring solutions have powered more than 100 clinical trials since 2007, and are proving to be a reliable choice for companies undertaking multi-center clinical trials.

April 24, 2018

·

2 min read

Policy

Prothena Shareholder Alert - PRTA Stock Drops Almost 70% - Kehoe Law Firm, P.C. Investigating

Kehoe Law Firm, P.C. is conducting a securities investigation on behalf of investors of Prothena Corporation plc (NASDAQ: PRTA) to determine whether Prothena Corporation and certain of its officers or directors engaged in securities fraud or other unlawful business practices.

April 24, 2018

·

1 min read